Printer Friendly

CHAIRMAN AND CEO OF CYTOGEN CORPORATION ELECTED TO WEST COMPANY BOARD

 PHOENIXVILLE, Pa., Dec. 15 /PRNewswire/ -- The West Company, Incorporated (NYSE: WST) announced today the election of George W. Ebright as a director of the company.
 Ebright is chairman of the board of directors and chief executive officer of Cytogen Corporation, the Princeton, N.J., biotechnology company engaged in the development of pharmaceuticals for the diagnosis and treatment of cancer. Ebright's election increases the number of directors to 13.
 Before joining Cytogen in 1989, Ebright was with SmithKline Beckman for 26 years, retiring as president and chief operating officer. During his career at SmithKline, Ebright played a key role in the launch of the successful ulcer drug, Tagamet.
 Ebright graduated from Franklin and Marshall College in 1960 with a degree in economics and earned his MBA from the University of Delaware in 1965.
 In addition to his position at Cytogen, Ebright is also a member of the board of directors of the Industrial Biotechnology Association, ECRI and Univax Biologics, Inc.
 The West Company is a premier supplier of products that satisfy the unique filling, sealing and dispensing needs of the health care and consumer products industries. More than 85 percent of West's revenue is generated by the health care markets. Products include stoppers, closures, containers, medical device components and assemblies made from elastomers, metal, plastic and glass. West also manufactures related packaging machinery.
 /delval/
 -0- 12/15/92
 /CONTACT: Stephen M. Heumann, corporate treasurer of The West Company, 215-935-4640/
 (WST)


CO: The West Company, Incorporated ST: Pennsylvania IN: SU: PER

CC-MJ -- PH029 -- 7349 12/15/92 15:42 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Dec 15, 1992
Words:258
Previous Article:THE WEST COMPANY ANNOUNCES FIRST QUARTER DIVIDEND
Next Article:SHARED MEDICAL SYSTEMS CORPORATION REPORTS DECLARATION OF DIVIDEND ON COMMON STOCK
Topics:


Related Articles
CYTOGEN ANNOUNCES RESIGNATION OF MARTIN D. CLEARY
DR. THOMAS J. MCKEARN APPOINTED CEO OF CYTOGEN
ARROW INTERNATIONAL ELECTS GEORGE W. EBRIGHT AS A DIRECTOR
CYTOGEN ANNOUNCES ELECTION OF AUSTIN TO BOARD OF DIRECTORS
CYTOGEN ANNOUNCES ELECTION OF WILLIAM C. MILLS III AS CHAIRMAN OF THE BOARD
ROBERT F. HENDRICKSON ELECTED TO CYTOGEN'S BOARD OF DIRECTORS
DONALD E. O'NEILL APPOINTED TO CYTOGEN BOARD OF DIRECTORS
CYTOGEN BOARD OF DIRECTORS NAMES THOMAS J. MCKEARN AS CHAIRMAN
Cytogen Corporation Announces Changes in Senior Management.
Cytogen Announces the Approval of Several Proposals at its Annual Meeting of Stockholders.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters